AD pathogenesis involves multiple pathological processes, including amyloid-beta (Aβ) protein deposition, neurofibrillary tangles from Tau protein phosphorylation, chronic neuroinflammation, and disrupted insulin signaling in the brain, alongside genetic factors and environmental exposures (2, 3, 7–9). The gene discussed is MAPT; the disease is Alzheimer disease.